| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A COMPARISON BETWEEN ULTRASOUND IMAGING AND CT FOR BBN-DRIVEN BLADDER CANCER MOUSE MODEL
|
Sholklapper, Tamir
|
|
|
42 |
S |
p. S39
|
artikel
|
| 2 |
A COMPARISON OF MAGNETIC RESONANCE IMAGING-BASED RISK CALCULATORS TO PREDICT PROSTATE CANCER RISK IN EUROPEAN AND NORTH AMERICAN COHORTS
|
Patel, Hiten D.
|
|
|
42 |
S |
p. S93
|
artikel
|
| 3 |
ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1A KIDNEY TUMORS: CONTEMPORARY RESULTS AFTER FOURTEN-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY
|
Alkatib, Khalid Y.
|
|
|
42 |
S |
p. S72-S73
|
artikel
|
| 4 |
ADJUVANT PEMBROLIZUMAB FOR RENAL CELL CARCINOMA (KEYNOTE-564): EXPLORATORY ANALYSIS ACROSS UCLA INTEGRATED STAGING SYSTEM RISK GROUPS AND DISEASE STAGE
|
Zhang, Tian
|
|
|
42 |
S |
p. S7-S8
|
artikel
|
| 5 |
ADOPTION, COST, AND THE ECONLY OF SCALE OF ROBOTIC VERSUS LAPAROSCOPIC RADICAL NEPHRECTOMY PROCEDURES
|
Zhu, Alec
|
|
|
42 |
S |
p. S39
|
artikel
|
| 6 |
ADVANCED-1: PHASE 1A DOSE-FINDING, OPEN-LABEL STUDY TO EVALUATE SAFETY AND TOXICITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER
|
Bandari, Jathin
|
|
|
42 |
S |
p. S61
|
artikel
|
| 7 |
AIM HIGH: EPIGENETIC MODULATION AND IMMUNE STIMULATION IN BLADDER CANCER
|
Koehne, Elizabeth
|
|
|
42 |
S |
p. S34
|
artikel
|
| 8 |
ALANINE RESTRICTION CAN INHIBIT CARCINOGENESIS IN A NOVEL MOUSE MODEL OF UPPER TRACT UROTHELIAL CARCINOMA
|
Yamamoto, Akinaru
|
|
|
42 |
S |
p. S20
|
artikel
|
| 9 |
ALTERATIONS IN THE GUT MICROBIOME ARE ASSOCIATED WITH THE DEVELOPMENT OF POSTOPERATIVE ILEUS AND INFECTIONS IN PATIENTS UNDERGOING CYSTECTOMY AND URINARY DIVERSION
|
Alsyouf, Muhannad
|
|
|
42 |
S |
p. S24
|
artikel
|
| 10 |
AMONG PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), OVERALL SURVIVAL IS SUBSTANTIALLY WORSE THAN BLADDER-CANCER SPECIFIC SURVIVAL: A NATIONAL VA COHORT STUDY
|
McGonagle, Kathryn E.
|
|
|
42 |
S |
p. S68
|
artikel
|
| 11 |
A MULTI-LEVEL APPROACH TO ANALYZING GEOGRAPHIC AND DEMOGRAPHIC FACTORS IN PROSTATE CANCER CLINICAL TRIALS
|
Gangidi, Suma
|
|
|
42 |
S |
p. S78
|
artikel
|
| 12 |
A NATIONAL ANALYSIS EVALUATING THE ROLE OF LYMPH NODE DISSECTION IN PATIENTS WITH HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA
|
Sabbagh, Saad
|
|
|
42 |
S |
p. S106-S107
|
artikel
|
| 13 |
A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC)
|
Liao, Ross
|
|
|
42 |
S |
p. S31
|
artikel
|
| 14 |
A PHASE IIB RANDOMIZED PLACEBO-CONTROLLED TRIAL TESTING A LONG-CHAIN OMEGA-3 FATTY ACID MAG-EPA DIETARY SUPPLEMENT ON PROSTATE CANCER AND GUT MICROBIOME
|
Fradet, Vincent
|
|
|
42 |
S |
p. S20
|
artikel
|
| 15 |
APPLICATION OF THE STRATCANS CRITERIA TO THE MUSIC AS COHORT: A STEP TOWARDS RISK STRATIFIED ACTIVE SURVEILLANCE
|
Wang, Michael
|
|
|
42 |
S |
p. S82
|
artikel
|
| 16 |
ARID1A DEFICIENCY PRIMES AN INVASIVE TRANSFORMATION IN METASTATIC BLADDER CANCER
|
D'Andrea, Vincent
|
|
|
42 |
S |
p. S32
|
artikel
|
| 17 |
ARTIFICIAL INTELLIGENCE-ENABLED LABEL-FREE MULTISPECTRAL IMAGING FOR IMPROVING THE QUALITY OF TRANSURETHRAL RESECTION OF BLADDER TUMOR PROCEDURES
|
Meraney, Anoop
|
|
|
42 |
S |
p. S47
|
artikel
|
| 18 |
ASCERTAINING PROVIDER-LEVEL IMPLICIT BIAS IN THE TREATMENT OF PROSTATE CANCER UTILIZING NATURAL LANGUAGE PROCESSING TECHNIQUES
|
Ramaswamy, Ashwin
|
|
|
42 |
S |
p. S86
|
artikel
|
| 19 |
ASSESSING MOLECULAR HETEROGENEITY OF PROSTATE CANCER BIOPSY SAMPLING: INSIGHTS FROM THE MAST TRIAL
|
Ajami, Tarek
|
|
|
42 |
S |
p. S90
|
artikel
|
| 20 |
ASSESSING THE CLINICAL IMPACT AND COSTS OF INCISIONAL NEGATIVE PRESSURE WOUND THERAPY FOR PREVENTING SURGICAL WOUND COMPLICATIONS AFTER RADICAL CYSTECTOMY
|
Rodriguez-Mahon, Katherine
|
|
|
42 |
S |
p. S62-S63
|
artikel
|
| 21 |
ASSESSMENT OF PSMA PET IMAGING RESPONSE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER 225AC-J591 THERAPY: POST-HOC PATIENT-LEVEL ANALYSIS OF A PROSPECTIVE CLINICAL TRIAL
|
Ricaurte-Fajardo, Andres
|
|
|
42 |
S |
p. S103
|
artikel
|
| 22 |
ASSOCIATION BETWEEN DIETARY NUTRIENTS AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
|
Su, Zhuo Tony
|
|
|
42 |
S |
p. S96
|
artikel
|
| 23 |
ASSOCIATION BETWEEN SMOKING BURDERN AND ONCOLOGIC OUTCOMES OF UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST COLLABORATION
|
Bhanvadia, Raj R.
|
|
|
42 |
S |
p. S25-S26
|
artikel
|
| 24 |
ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY
|
Sekar, Rishi R.
|
|
|
42 |
S |
p. S13-S14
|
artikel
|
| 25 |
ASSOCIATION OF PROTON PUMP INHIBITORS CUMULATIVE USE WITH PROSTATE CANCER RISK AND ADVERSE OUTCOMES: A POPULATION-BASED ANALYSIS
|
Sayyid, Rashid
|
|
|
42 |
S |
p. S89
|
artikel
|
| 26 |
BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS
|
Durant, Adri
|
|
|
42 |
S |
p. S59
|
artikel
|
| 27 |
BCG INDUCTION WITH GEMCITABINE/DOCETAXEL MAINTENANCE VS. GEMCITABINE/DOCETAXEL INDUCTION AND MAINTENANCE AS ADJUVANT THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
|
David, Reuben Ben
|
|
|
42 |
S |
p. S56
|
artikel
|
| 28 |
BLADDER CANCER SUSCEPTIBILITY: UNVEILING MODIFIABLE AND NON-MODIFIABLE RISK FACTORS.
|
Parekh, Sneha
|
|
|
42 |
S |
p. S38-S39
|
artikel
|
| 29 |
BLOOD-BASED LIQUID BIOPSY IN DIAGNOSIS, SURVEILLANCE, AND PROGNOSIS OF PATIENTS WITH PRIMARY UPPER TRACT UROTHELIAL CARCINOMA
|
Ghoreifi, Alireza
|
|
|
42 |
S |
p. S21
|
artikel
|
| 30 |
CAN AI BE USEFUL AS A CLINICAL TOOL FOR RISK STRATIFYING LOCALIZED PROSTATE CANCER PATIENTS?
|
White, Randie
|
|
|
42 |
S |
p. S83
|
artikel
|
| 31 |
CARCINOMA IN SITU AND URINARY CYTOLOGY AS AN INDICATOR OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BCG
|
Katims, Andrew B.
|
|
|
42 |
S |
p. S46
|
artikel
|
| 32 |
CHANGES IN PROSTATE SPECIFIC ANTIGEN SCREENING FOLLOWING THE 2018 UNITED STATES PREVENTIVE SERVICES TASK FORCE GUIDELINES AND THROUGH THE COVID-19 PANDEMIC
|
Qian, Zhiyu (Jason)
|
|
|
42 |
S |
p. S90
|
artikel
|
| 33 |
CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF PATIENTS WITH A FAMILY HISTORY OF PROSTATE CANCER AFTER PROGRESSION TO MCRPC: A POST HOC ANALYSIS OF THE TRUMPET REGISTRY
|
Karsh, Lawrence
|
|
|
42 |
S |
p. S16-S17
|
artikel
|
| 34 |
CHARACTERISTRICS AND NON-ONCOLOGICAL OUTCOMES OF PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH LEUPROLIDE OR RELUGOLIX
|
Ho, Austin Y.
|
|
|
42 |
S |
p. S74
|
artikel
|
| 35 |
CHARACTERIZATION OF NAV1.7 EXPRESSION IN PROSTATIC NERVES FOLLOWING RADICAL PROSTATECTOMY
|
Doudt, Alexander
|
|
|
42 |
S |
p. S73
|
artikel
|
| 36 |
CHARACTERIZATION OF PERIOPERATIVE TESTOSTERONE LEVELS AND ASSOCIATION WITH POSTOPERATIVE OUTCOME AND HISTOLOGIC FINDINGS IN MEN WITH BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY
|
Broenimann, Stephan
|
|
|
42 |
S |
p. S26
|
artikel
|
| 37 |
CHARACTERIZATION OF VON HIPPEL-LINDAU PATIENTS WITH METASTATIC PHEOCHROMOCYTOMA
|
Solomon, Julie R.
|
|
|
42 |
S |
p. S104-S105
|
artikel
|
| 38 |
CHARACTERIZING CLINICALLY SIGNIFICANT PROSTATE CANCER DETECTED ONLY BY SYSTEMATIC BIOPSY IN AN MRI-TARGETED BIOPSY PARADIGM
|
Fletcher, Sean A.
|
|
|
42 |
S |
p. S84
|
artikel
|
| 39 |
CHARACTERIZING PSYCHOLOGICAL RESOURCES AND RESILIENCE IN PATIENTS WITH BLADDER CANCER: ASSOCIATIONS WITH FRAILTY AND QUALITY OF LIFE
|
Petersen, Erin
|
|
|
42 |
S |
p. S60-S61
|
artikel
|
| 40 |
CHATGPT USE IN PATIENT AND TRAINEE EDUCATION FOR RENAL MASSES AND RENAL CELL CARCINOMA
|
Mershon, John Patrick
|
|
|
42 |
S |
p. S4-S5
|
artikel
|
| 41 |
CHEST CT SHOULD REPLACE CHEST X-RAYS TO EVALUATE FOR THORACIC RENAL CELL CARCINOMA METASTASES
|
Das, Arighno
|
|
|
42 |
S |
p. S2
|
artikel
|
| 42 |
CLINICAL, MOLECULAR AND IMMUNOHISTOCHEMICAL PROFILES OF CLEAR CELL ADENOCARCINOMA OF THE URINARY TRACT
|
Koll, Florestan
|
|
|
42 |
S |
p. S35
|
artikel
|
| 43 |
CLINICAL OUTCOMES OF PATIENTS ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER WITH SMALL INDEX LESIONS ON MRI
|
Siva, Jayant
|
|
|
42 |
S |
p. S15
|
artikel
|
| 44 |
COMPARATIVE ANALYSIS OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN PT3AN0M0 RENAL CELL CARCINOMA: A MULTICENTER PROPENSITY SCORE-MATCHED ANALYSIS
|
Saitta, Cesare
|
|
|
42 |
S |
p. S40-S41
|
artikel
|
| 45 |
COMPARING ACTIVE SURVEILLANCE AND WATCHFUL WAITING AND RADICAL TREATMENT USING MACHINE LEARNING MODELS AMONG PROSTATE CANCER PATIENTS
|
HU, SIQI
|
|
|
42 |
S |
p. S89-S90
|
artikel
|
| 46 |
COMPARING INFECTIOUS COMPLICATIONS IN PATIENTS UNDERGOING TRANSPERINEAL BIOPSY WITH AND WITHOUT ANTIBIOTIC PROPHYLAXIS
|
Leonard, Steven
|
|
|
42 |
S |
p. S84
|
artikel
|
| 47 |
COMPARING WHITE LIGHT VERSUS BLUE LIGHT CYSTOSCOPY RECURRENCE OUTCOMES AMONG NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS IN AN EQUAL ACCESS SETTING: A PROPENSITY SCORED MATCHED ANALYSIS
|
Das, Sanjay
|
|
|
42 |
S |
p. S69-S70
|
artikel
|
| 48 |
COMPARISON OF APIXABAN VERSUS ENOXAPARIN FOR EXTENDED PROPHYLAXIS AFTER RADICAL CYSTECTOMY (CARE)
|
Michel, Katharine
|
|
|
42 |
S |
p. S28
|
artikel
|
| 49 |
COMPARISON OF PARTIAL GLAND CRYOABLATION AND ROBOTIC RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCHED ANALYSIS
|
Zhu, Alec
|
|
|
42 |
S |
p. S85-S86
|
artikel
|
| 50 |
COMPLICATIONS ASSOCIATED WITH INCREASED LYMPH NODE COUNTS DURING RADICAL PROSTATECTOMY
|
Chua, Kevin
|
|
|
42 |
S |
p. S88
|
artikel
|
| 51 |
COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT BLOCKADE
|
Reese, Stephen
|
|
|
42 |
S |
p. S44
|
artikel
|
| 52 |
COMUTATIONAL PATTERNS IN FGFR3-ALTERED NON-MUSCLE INVASIVE BLADDER CANCER INFLUENCE RECURRENCE AND PROGRESSION
|
D'Souza, Neeta
|
|
|
42 |
S |
p. S55
|
artikel
|
| 53 |
CONCOMITANT NALOXONE AND OPIOID PRESCRIBING ASSOCIATED WITH INCREASED RATES OF SUBSCANCE USE DISORDER AND DEATH FOLLOWING UROLOGIC ONCOLOGIC PROCEDURES
|
Shah, Sohan S.
|
|
|
42 |
S |
p. S107
|
artikel
|
| 54 |
CONCOMITANT SECOND-GENERATION HORMONE THERAPY WITH RADIUM-223 IN THE THIRD-LINE SETTING: DOES IT IMPROVE OVERALL SURVIVAL?
|
Lehner, Kelly
|
|
|
42 |
S |
p. S11
|
artikel
|
| 55 |
CONDITIONAL SURVIVAL IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
|
Bendre, Hersh
|
|
|
42 |
S |
p. S97
|
artikel
|
| 56 |
CONNEXIN-26 EXPRESSION IS ASSOCIATED WITH DISEASE OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA AND MAY BE A SOURCE OF INTRATUMORAL ADENOSINE
|
Ellis, Elizabeth
|
|
|
42 |
S |
p. S3-S4
|
artikel
|
| 57 |
CONSISTENT PERFORMANCE OF BLADDER EPICHECK FOR NMIBC SURVEILLANCE IN THE USA AND EUROPEAN PIVOTAL STUDIES AND IN REAL WORLD STUDIES
|
Fleshner, Neil
|
|
|
42 |
S |
p. S63
|
artikel
|
| 58 |
CONTEMPORARY PATTERNS IN PROSTATE CANCER SCREENING PATTERNS AMONG LGBTQ+ PATIENTS
|
Roberson, Daniel
|
|
|
42 |
S |
p. S77
|
artikel
|
| 59 |
Cover 2 - Masthead
|
|
|
|
42 |
S |
p. IFC
|
artikel
|
| 60 |
C-REACTIVE PROTEIN KINETICS ARE ASSOCIATED WITH PROGRESSION AND SURVIVAL IN SURGICALLY TREATED RENAL CELL CARCINOMA PATIENTS
|
Saitta, Cesare
|
|
|
42 |
S |
p. S65
|
artikel
|
| 61 |
CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY
|
Meagher, Margaret Frances
|
|
|
42 |
S |
p. S5
|
artikel
|
| 62 |
DATA-INDEPENDENT ACQUISITION MASS SPECTROMETRY (DIA-MS) OF UROTHELIAL CARCINOMA RESULTS IN DISTINCT PROTEOMIC SIGNATURES
|
Noel, Onika
|
|
|
42 |
S |
p. S64
|
artikel
|
| 63 |
DECIPHER® GENOMIC CLASSIFIER ON INITIAL PROSTATE BIOPSY IS ASSOCIATED WITH GLEASON SCORE UPGRADING ON FINAL RADICAL PROSTATECTOMY PATHOLOY
|
Sheng, John
|
|
|
42 |
S |
p. S94
|
artikel
|
| 64 |
DECIPHER® GENOMIC CLASSIFIER SCORE ON INITIAL BIOPSY IS ASSOCIATED WITH PROGRESSION FORM ACTIVE SURVEILLANCE TO TREATMENT IN PROSTATE CANCER
|
Sheng, John
|
|
|
42 |
S |
p. S98-S99
|
artikel
|
| 65 |
DECOMPRESSION OR NOT: THE ONGOING CHALLENGE OF MALIGNANT HYDRONEPHROSIS
|
Magee, Diana
|
|
|
42 |
S |
p. S92
|
artikel
|
| 66 |
DEFINING A SIZE THRESHOLD FOR PERCUTANEOUS MICROWAVE ABLATION FOR CLINICAL T1 RENAL CELL CARCINOMA BY COMPARING ONCOLOGIC OUTCOMES WITH SURGICALLY TREATED PATIENTS
|
Das, Arighno
|
|
|
42 |
S |
p. S71
|
artikel
|
| 67 |
DEFINING THE IMPACT OF PERSONAL AND FAMILY HISTORY OF LYNCH-SYNDROME ASSOCIATED CANCERS ON CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
|
Truong, Hong
|
|
|
42 |
S |
p. S22
|
artikel
|
| 68 |
DEMOGRAPHIC DISPARITIES IN PENILE CANCER IN APPALACHIA: A MULTI-INSTITUTIONAL, STATEWIDE REVIEW
|
Zekan, David
|
|
|
42 |
S |
p. S66
|
artikel
|
| 69 |
DETECTION, RISK STRATIFICATION, AND THERAPUETIC SELECTION FOR UPPER TRACT UROTHELIAL CARCINOMA WITH URINE-BASED COMPREHENSIVE GENOMIC PROFILING
|
Yonover, Paul M.
|
|
|
42 |
S |
p. S25
|
artikel
|
| 70 |
DEVELOPMENT AND EXTERNAL VALIDATION OF NIMBLE, AN ARTIFICIAL INTELLIGENCE-BASED TOOL TO PREDICT PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCER: A RETROSPECTIVE MULTI-INSTITUTIONAL COHORT STUDY
|
Kwong, Jethro C.C.
|
|
|
42 |
S |
p. S53-S54
|
artikel
|
| 71 |
DEVELOPMENT AND TESTING OF A CUSTOM NANOSTRING RNA CODESET FOR MUSCLE-INVASIVE BLADDER CANCER UTILIZING TCGA SUBTYPING (SWOG S1011)
|
Patel, Sagar R
|
|
|
42 |
S |
p. S31-S32
|
artikel
|
| 72 |
DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
|
Saitta, Cesare
|
|
|
42 |
S |
p. S103
|
artikel
|
| 73 |
DEVELOPMENT OF A GENOMIC PREDICTION MODEL FOR UPPER TRACT UROTHELIAL CARCINOMA STAGE
|
Katims, Andrew B.
|
|
|
42 |
S |
p. S21
|
artikel
|
| 74 |
DEVELOPMENT OF A NOVEL NOMOGRAM TO PREDICT BENIGN LESION PATHOLOGY IN PATIENTS AFFECTED BY RENAL MASSES: ANALYSIS OF THE INMARC REGISTRY.
|
Afari, Jonathan A.
|
|
|
42 |
S |
p. S42
|
artikel
|
| 75 |
DEVELOPMENT OF NODESAFE A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE METASTASIS OR RECURRENCE AT THE TIME OF OR FOLLOWING NEPHRECTOMY.
|
Saitta, Cesare
|
|
|
42 |
S |
p. S39-S40
|
artikel
|
| 76 |
DIAGNOSTIC DILEMMAS IN PROSTATIC STROMAL-INVASIVE UCC WITH VARIANT HISTOLOGY
|
Croll, Benjamin
|
|
|
42 |
S |
p. S59-S60
|
artikel
|
| 77 |
DISCORDANCE BETWEEN TREATMENT EFFECTS OBSERVED IN ANIMAL EXPERIMENTS AND CLINICAL TRIALS IN NON-MUSCLE INVASIVE BLADDER CANCER
|
Trecarten, Shaun
|
|
|
42 |
S |
p. S51-S52
|
artikel
|
| 78 |
DISEASE PROGRESSION IN BCG UNRESPONSIVE PATIENTS: STRATIFICATION OF CIS CONTAINING TUMORS
|
Guske, Christopher W
|
|
|
42 |
S |
p. S47
|
artikel
|
| 79 |
DISPARITIES IN UTILIZATION OF GENETIC EVALUATION IN PATIENTS WITH KIDNEY CANCER WHO MEET GUIDELINES FOR GENETIC REFERRAL
|
Makarova, Elizaveta
|
|
|
42 |
S |
p. S2
|
artikel
|
| 80 |
DOES GENOMIC RISK SCORE AT BIOPSY CORRELATE WITH FOCALITY OF DISEASE AT RADICAL PROSTATECTOMY: IMPLICATIONS FOR FOCAL THERAPY CANDIDATES
|
Winebaum, Jenna
|
|
|
42 |
S |
p. S80
|
artikel
|
| 81 |
EARLY ADVERSE EVENTS, EMERGENCY ROOM VISITS AND HOSPITALIZATIONS AFTER PSMA BASED RLT: A RETROSPECTIVE ANALYSIS FROM REAL WORLD THERANOSTICS PRACTICE
|
Ahmed, Mohamed E.
|
|
|
42 |
S |
p. S12
|
artikel
|
| 82 |
EARLY CLINICAL EXPERIENCE WITH SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL FOR TREATMENT-NAIVE HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER
|
Refugia, Justin Manuel
|
|
|
42 |
S |
p. S49-S50
|
artikel
|
| 83 |
Editorial Board
|
|
|
|
42 |
S |
p. i
|
artikel
|
| 84 |
EFFECT OF TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY ON THE QUALITY OF HYDROGEL SPACER PLACEMENT IN MEN UNDERGOING RADIATION THERAPY FOR PROSTATE CANCER
|
Rezaee, Michael E.
|
|
|
42 |
S |
p. S100
|
artikel
|
| 85 |
EFFICACY OF CYTOREDUCTIVE CYSTECTOMY IN METASTATIC UROTHELIAL BLADDER CANCER BASED ON SITE OF METASTASIS
|
Xu, Vincent Eric
|
|
|
42 |
S |
p. S32
|
artikel
|
| 86 |
EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL
|
Boorjian, Stephen A.
|
|
|
42 |
S |
p. S70
|
artikel
|
| 87 |
ELEVATED PERIPROSTATIC VENOUS TESTOSTERONE CORRELATES WITH PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
|
Michael, Patrick Durfee
|
|
|
42 |
S |
p. S89
|
artikel
|
| 88 |
EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND PD-1/PD-L1 SIGNALING PROVIDE RECIPROCAL FEEDBACK IN RENAL CELL CARCINOMA PROGRESSION WITH IMPLICATIONS FOR IMMUNOTHERAPY RESPONSE
|
Wainstein, Matthew D.
|
|
|
42 |
S |
p. S5-S6
|
artikel
|
| 89 |
ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL
|
Rezaee, Michael E.
|
|
|
42 |
S |
p. S54
|
artikel
|
| 90 |
ERBB2 ALTERATIONS IN NON-MUSCLE INVASIVE BLADDER CANCER ARE ASSOCIATED WITH A DISTINCT GENOMIC SIGNATURE
|
Alam, Syed Muneeb
|
|
|
42 |
S |
p. S58
|
artikel
|
| 91 |
ESTABLISHMENT OF A DOUBLE-HUMANIZED MOUSE MODEL USING PATIENT-DERIVED XENOGRAFT BLADDER CANCER TUMOR CELL LINE AND HUMAN γδ T-CELLS
|
Trecarten, Shaun
|
|
|
42 |
S |
p. S57
|
artikel
|
| 92 |
EVALUATING EFFICACY OF GENETIC RISK EVALUATION FOR PATIENTS ≤ 46 YEARS OF AGE WITH RENAL CELL CARCINOMA
|
Chen, Lan
|
|
|
42 |
S |
p. S43
|
artikel
|
| 93 |
EVALUATING THE EFFICACY OF INTRAVESICAL LACTOBACILLUS RHAMNOSUS GG AS A NOVEL THERAPEUTIC APPROACH IN BBN MURINE MODEL OF BLADDER CANCER
|
Helstrom, Emma
|
|
|
42 |
S |
p. S48-S49
|
artikel
|
| 94 |
EVALUATING THE IMPACT OF LYMPOVASCULAR INVASION ON SURVIVAL OF SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA: A NATIONWIDE ANALYSIS
|
Corsi, Nicholas
|
|
|
42 |
S |
p. S106
|
artikel
|
| 95 |
EVALUATING USE OF A GENETIC RISK SCORE TO IMPROVE PROSTATE CANCER RISK STRATIFICATION IN BLACK MEN: A RETROSPECTIVE PILOT STUDY
|
Fletcher, Sean A.
|
|
|
42 |
S |
p. S95-S96
|
artikel
|
| 96 |
EVALUATION OF GENOMIC AND TRANSCRIPTOMIC ALTERATIONS AND INTRATUMORAL HETEROGENEITY IN SMALL RENAL MASSES UPSTAGED TO PATHOLOGIC T3A CLEAR CELL RENAL CELL CARCINOMA
|
Gessner, Kathryn Hacker
|
|
|
42 |
S |
p. S68
|
artikel
|
| 97 |
EVALUATION OF TRANSITIONAL ZONE LESIONS ON MULTIPARAMETRIC MRI AND MRI-TARGETED BIOPSY IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE COMMUNITY SETTING: A RETROSPECTIVE STUDY
|
Taylor, Zachariah
|
|
|
42 |
S |
p. S101-S102
|
artikel
|
| 98 |
EXAMINING SURVIVAL OUTCOMES AND MOLECULAR DRIVERS OF TESTIS CANCER IN HISPANIC MEN
|
Rezaee, Michael E.
|
|
|
42 |
S |
p. S105
|
artikel
|
| 99 |
EXPOSURE OF ENVIRONMENTAL TRACE ELEMENTS IN PROSTATE CANCER PATIENTS: RISK ANALYSIS IN MULTIPLE LEVELS
|
Fu, Hangcheng
|
|
|
42 |
S |
p. S88
|
artikel
|
| 100 |
FACTORS ASSOCIATED WITH 30-DAY POST-SURGERY MORTALITY FOLLOWING MAJOR UROLOGIC CANCER SURGERY - CONTEMPORARY ANALYSIS OF THE 2019-2021 NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATA
|
Consalvo, Alexis
|
|
|
42 |
S |
p. S102
|
artikel
|
| 101 |
FACTORS ASSOCIATED WITH PSMA POSITIVITY AT LOW PSA AFTER RADICAL PROSTATECTOMY
|
Li, Eric V.
|
|
|
42 |
S |
p. S87
|
artikel
|
| 102 |
FEASIBILITY AND OUTCOMES OF INTERVENTIONS TO REDUCE CYSTOSCOPY DISCOMFORT: A QUALITY IMPROVEMENT PILOT
|
Desai, Avani
|
|
|
42 |
S |
p. S8-S9
|
artikel
|
| 103 |
FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT
|
Mason, J. Bradley
|
|
|
42 |
S |
p. S93
|
artikel
|
| 104 |
FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER
|
Tholomier, Côme
|
|
|
42 |
S |
p. S27
|
artikel
|
| 105 |
GDF15 PROPEPTIDE IS A NOVEL BLOOD BIOMARKER OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER BY ENHANCING THE VICIOUS CYCLE OF BONE METASTASIS
|
Yamamichi, Gaku
|
|
|
42 |
S |
p. S14-S15
|
artikel
|
| 106 |
GEMCITABINE AND DOCETAXEL INDUCTION ONLY VERSUS INDUCTION WITH MAINTENANCE IN LOW-RISK AND INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER
|
David, Reuben Ben
|
|
|
42 |
S |
p. S56-S57
|
artikel
|
| 107 |
GENOMIC CHARACTERIZATION OF HIGH-GRADE TA UROTHELIAL CARCINOMA WITH AND WITHOUT CARCINOMA IN SITU
|
Tallman, Jacob E
|
|
|
42 |
S |
p. S62
|
artikel
|
| 108 |
GENOMIC LANDSCAPE AND OPPORTUNITIES FOR TARGETED AND IMMUNOTHERAPIES IN PATIENTS WITH TMPRSS2:ERG FUSION POSITIVE VS. WILD TYPE CASTRATE RESISTANT PROSTATE CANCER
|
Basin, Michael F.
|
|
|
42 |
S |
p. S12
|
artikel
|
| 109 |
GERM CELL TUMORS IN THE US MILITARY: A CRITICAL ANALYSIS OF PRESENTATION AND TREATMENT
|
Woodle, Tarah
|
|
|
42 |
S |
p. S107-S108
|
artikel
|
| 110 |
GERMLINE VARIANTS LINKED TO OVARIAN AND BLADDER CANCER IN FEMALES: IS OVARY SPARING RADICAL CYSTECTOMY AN OPTION?
|
Davis, Laura Elizabeth
|
|
|
42 |
S |
p. S29
|
artikel
|
| 111 |
GRADE AND VOLUME PROGRESSION AND ITS ASSOCIATION WITH THE DECIPHER GENOMIC CLASSIFIER USING PATIENTS ENROLLED IN A PROSPECTIVE ACTIVE SURVEILLANCE PROTOCOL
|
Khandekar, Archan
|
|
|
42 |
S |
p. S91-S92
|
artikel
|
| 112 |
GROWTH KINETICS OF VENOUS TUMOR THROMBUS IN PATIENTS WITH RENAL CELL CARCINOMA
|
Barashi, Nimrod S
|
|
|
42 |
S |
p. S6
|
artikel
|
| 113 |
HAVE WE REACHED THE “OPTIMAL” UTILIZATION OF PNX FOR LARGER TUMORS? BALANCING SAFETY, ONCOLOGIC OUTCOMES AND RENAL FUNCTION PRESERVATION
|
Abouassaly, Robert
|
|
|
42 |
S |
p. S69
|
artikel
|
| 114 |
HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY OR OTHER SUBTYPES NOT A PREDICTOR FOR PROGRESSION IN BCG-TREATED PATIENTS
|
Calkins, Daniel Craig
|
|
|
42 |
S |
p. S52
|
artikel
|
| 115 |
HUMANISTIC BURDEN ASSOCIATED WITH INTRAVESICAL TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER IN THE UNITED STATES
|
Ireland, Andrea
|
|
|
42 |
S |
p. S65
|
artikel
|
| 116 |
HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHRECTOMY FOR RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC REGISTRY
|
Saitta, Cesare
|
|
|
42 |
S |
p. S40
|
artikel
|
| 117 |
IDENTIFYING THE DRIVER HISTOLOGY RESPONSIBLE FOR THE INFERIOR CLINICOPATHOLOGIC FEATURES ASSOCIATED WITH PLASMACYTOID BLADDER CANCER
|
Davaro, Facundo
|
|
|
42 |
S |
p. S22
|
artikel
|
| 118 |
IMAGING PERFORMANCE FOR GENITOURINARY CANCERS IN A LARGE SINGLE INSTITUTION HEMATURIA POPULATION WITHOUT PREVIOUS UROLOGIC EVALUATION
|
Bochner, Emily
|
|
|
42 |
S |
p. S66
|
artikel
|
| 119 |
IMMUNOTHERAPY UTILIZATION PATTERNS IN METASTATIC BLADDER CANCER: ASSESSING INSURANCE STATUS AS A MODIFIABLE FACTOR ASSOCIATED WITH FAILURE TO RECEIVE NOVEL THERAPIES
|
Zhang, JJ H.
|
|
|
42 |
S |
p. S28
|
artikel
|
| 120 |
IMPACT OF BLADDER CUFF MANAGEMENT ON ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Alrumaih, Abullah
|
|
|
42 |
S |
p. S90-S91
|
artikel
|
| 121 |
IMPACT OF CHEMOTHERAPY ON ANXIETY, DEPRESSION, AND SUICIDALITY AMONGST TESTICULAR CANCER SURVIVORS
|
Meagher, Margaret
|
|
|
42 |
S |
p. S105
|
artikel
|
| 122 |
IMPACT OF 18F-DCFPYL PSMA PET ON ACCURACY OF mpMRI IN LOW AND INTERMEDIATE RISK PROSTATE CANCER: INTERIM ANALYSIS OF A PHASE II DIAGNOSTIC TRIAL
|
Bigarella, Marcelo P
|
|
|
42 |
S |
p. S99-S100
|
artikel
|
| 123 |
IMPACT OF NODAL DISEASE IN NON-CLEAR CELL RENAL CELL CARCINOMA AND THE ROLE OF SALVAGE LYMPH NODE RESECTION
|
Calderon, Lina Posada
|
|
|
42 |
S |
p. S44
|
artikel
|
| 124 |
IMPACT OF OBESITY ON SURGICALLY-INDUCED RENAL FUNCTIONAL DECLINE FOLLOWING RADICAL AND PARTIAL NEPHRECTOMY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC) DATABASE
|
Afari, Jonathan A.
|
|
|
42 |
S |
p. S42
|
artikel
|
| 125 |
IMPACT OF PI-RADS 5 LESIONS ON ACTIVE SURVEILLANCE FOR GRADE GROUP 1
|
Azari, Sarah
|
|
|
42 |
S |
p. S95
|
artikel
|
| 126 |
IMPACT OF PROSTATE SIZE ON THE OUTCOMES OF RADICAL PROSTATECTOMY
|
Deol, Ekamjit Singh
|
|
|
42 |
S |
p. S97
|
artikel
|
| 127 |
IMPACT OF SOCIOECONOMIC MARGINALIZATION STATUS ON STAGE AT DIAGNOSIS AND ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
|
Ringa, Maximiliano
|
|
|
42 |
S |
p. S50
|
artikel
|
| 128 |
IMPORTANCE OF PATHOLOGIC RE-REVIEW FOR PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER – EVALUATING CHANGE IN GRADE, CLINICAL T STAGE AND RISK STRATIFICATION
|
Campbell, Rebecca
|
|
|
42 |
S |
p. S55-S56
|
artikel
|
| 129 |
INCIDENCE AND FACTORS ASSOCIATED WITH INFECTIOUS COMPLICATIONS FOLLOWING MAJOR UROLOGIC CANCER SURGERIES IN THE UNITED STATES: CONTEMPORARY ANALYSIS OF THE 2019-2021 ACS NSQIP DATABASE
|
Pfail, John
|
|
|
42 |
S |
p. S93-S94
|
artikel
|
| 130 |
INCIDENTAL CARCINOMA AFTER SINGLE-PORT TRANSVESICAL ROBOT-ASSISTED SIMPLE PROSTATECTOMY
|
Ramos, Roxana
|
|
|
42 |
S |
p. S94-S95
|
artikel
|
| 131 |
INCORPORATING C-REACTIVE PROTEIN INTO THE TRIFECTA: IMPLICATIONS FOR SURVIVAL AND FUNCTIONAL OUTCOMES FOLLOWING PARTIAL NEPHRECTOMY
|
Yuen, Kit L.
|
|
|
42 |
S |
p. S68-S69
|
artikel
|
| 132 |
INFECTIONS AFTER ADOPTION OF ANTIBIOGRAM-DIRECTED PROPHYLAXIS AND INTRACORPOREAL URINARY DIVERSION FOR ROBOTIC-ASSISTED RADICAL CYSTECTOMY
|
Rich, Jordan Miller
|
|
|
42 |
S |
p. S23
|
artikel
|
| 133 |
INGESTION OF INORGANIC ARSENIC IN DRINKING WATER INDUCED UROGENITAL CARCINOGENESIS IN MICE MODELS
|
Fu, Hangcheng
|
|
|
42 |
S |
p. S35
|
artikel
|
| 134 |
INITIAL EVALUATION OF ADHERENCE TO AN ELECTRONIC DECISION SUPPORT TOOL FOR SHARED DECISION MAKING IN PROSTATE CANCER SCREENING IN THE PRIMARY CARE SETTING
|
Egan, Jillian
|
|
|
42 |
S |
p. S77
|
artikel
|
| 135 |
INITIAL FINDINGS FROM THE MULTI-INSTITUTIONAL SARCOMATOID RENAL CELL CARCINOMA CONSORTIUM (SaRCC)
|
Blum, Kyle A.
|
|
|
42 |
S |
p. S42-S43
|
artikel
|
| 136 |
INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY
|
Amini, Andrew
|
|
|
42 |
S |
p. S91
|
artikel
|
| 137 |
INTERNATIONAL VARIATIONS IN QUALITY METRICS FOR LOCALIZED PROSTATE CANCER
|
Weiner, Adam B.
|
|
|
42 |
S |
p. S91
|
artikel
|
| 138 |
INTER-RATER RELIABILITY AND DIAGNOSTIC ACCURACY OF PI-RADS SCORING BETWEEN ACADEMIC AND COMMUNITY CARE NETWORKS: HOW WIDE IS THE GAP
|
Sundaresan, Vinaik
|
|
|
42 |
S |
p. S101
|
artikel
|
| 139 |
IS PATHOLOGICAL UPSTAGING TO T3A RENAL CELL CARCINOMA ASSOCIATED WITH A SIMILAR PROGNOSIS TO NON-UPSTAGED PATHOLOGIC T3A DISEASE? A MULTICENTER ANALYSIS
|
Afari, Jonathan A.
|
|
|
42 |
S |
p. S41
|
artikel
|
| 140 |
LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES
|
Sager, Rebecca A.
|
|
|
42 |
S |
p. S69
|
artikel
|
| 141 |
LARGE LANGUAGE MODEL FOR PROVIDING PATIENT-FOCUSED GUIDANCE FOLLOWING RADICAL PROSTATECTOMY
|
Iranmahboub, Parsa
|
|
|
42 |
S |
p. S82
|
artikel
|
| 142 |
LEGEND, A PHASE 1/2 STUDY OF DETALIMOGENE VORAPLASMID (EG-70) INTRAVESICAL MONOTHERAPY DEMONSTRATED CLINICAL RESPONSES IN BCG-UNRESPONSIVE NMIBC PATIENTS WITH CIS
|
Steinberg, Gary
|
|
|
42 |
S |
p. S48
|
artikel
|
| 143 |
LENGTH OF URETER RESECTED AT TIME OF URINARY DIVERSION IS ASSOCIATED WITH URETERAL STRICTURE RATE
|
Das, Arighno
|
|
|
42 |
S |
p. S27
|
artikel
|
| 144 |
LEVERAGING DIGITAL SPATIAL PROFILING TO IDENTIFY TRANSCRIPTIONAL SIGNATURES ASSOCIATED WITH UROTHELIAL CARCINOMA IN SITU
|
Frydenlund, Noah
|
|
|
42 |
S |
p. S37
|
artikel
|
| 145 |
LIMITED UTILITY OF QUANTITATIVE THRESHOLDS ON 99MTC-SESTAMIBI SPECT/CT FOR DISTINGUISHING RENAL CELL CARCINOMA FROM ONCOCYTIC RENAL MASSES
|
Wang, Robert S.
|
|
|
42 |
S |
p. S6-S7
|
artikel
|
| 146 |
LONGITUDINAL CHANGES IN PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH HIGH-RISK BIOCHEMICALLY RECURRENT (BCR) NONMETASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (NMCSPC) FROM THE EMBARK STUDY
|
Freedland, Stephen J.
|
|
|
42 |
S |
p. S18
|
artikel
|
| 147 |
LONG-TERM OUTCOMES OF SURVEILLANCE OF CLINICAL STAGE I PURE TERATOMA OF THE TESTICLE
|
Chavarriaga, Julian
|
|
|
42 |
S |
p. S104
|
artikel
|
| 148 |
MANAGING PROSTATE CANCER AFTER PROCTOCOLECTOMY AND ILEAL POUCH-ANAL ANASTOMOSIS: FEASIBILITY AND OUTCOMES OF SINGLE-PORT TRANSVESICAL ROBOTIC-ASSISTED RADICAL PROSTATECTOMY.
|
Bermeo, Adriana Marcela Pedraza
|
|
|
42 |
S |
p. S14
|
artikel
|
| 149 |
MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS
|
Daneshmand, Siamak
|
|
|
42 |
S |
p. S58
|
artikel
|
| 150 |
MAYO ADHESIVE PROBABILITY SCORE IS ASSOCIATED WITH WORSE OVERALL SURVIVAL IN PATIENTS UNDERGOING SURGERY FOR CLINICAL STAGE T1 RENAL CELL CARCINOMA
|
Nicaise, Edouard
|
|
|
42 |
S |
p. S3
|
artikel
|
| 151 |
MECHANISMS AND STRATEGIES TO OVERCOME RESISTANCE TO ENFORTUMAB VEDOTIN IN BLADDER CANCER
|
Chang, Kevin
|
|
|
42 |
S |
p. S28-S29
|
artikel
|
| 152 |
MICROULTRASOUND IN CANCER – ACTIVE SURVEILLANCE (MUSIC-AS)
|
Albers, Patrick
|
|
|
42 |
S |
p. S82-S83
|
artikel
|
| 153 |
MOLECULAR CORRELATES WITH PSMA EXPRESSION IN PRIMARY PROSTATE CANCER
|
Weiner, Adam B.
|
|
|
42 |
S |
p. S85
|
artikel
|
| 154 |
MORPHOLOGICAL PROGRESSION IN RELAPSING PATIENTS WITH SMALL CELL BLADDER CANCER
|
Moussa, Mohammad Jad
|
|
|
42 |
S |
p. S30
|
artikel
|
| 155 |
MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: SINGLE INSTITUTION EXPERIENCE OF TREATMENT EFFICACY
|
Bochner, Emily
|
|
|
42 |
S |
p. S80
|
artikel
|
| 156 |
NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORT
|
Taylor, Jacob
|
|
|
42 |
S |
p. S49
|
artikel
|
| 157 |
NEGATIVE PREDICTIVE VALUE OF PROSTATE MRI IN REAL WORLD PRACTICE: RESULTS FROM A STATEWIDE SURGICAL COLLABORATIVE
|
Zhu, Alex
|
|
|
42 |
S |
p. S79
|
artikel
|
| 158 |
NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY (RNU) VS. RNU ALONE FOR UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COHORT ANALYSIS (ROBUUST COLLABORATIVE)
|
Corsi, Nicholas
|
|
|
42 |
S |
p. S24-S25
|
artikel
|
| 159 |
NEPCAPSULAR RECONSTRUCTION FOR CHALLENGING PARTIAL NEPHRECTOMY: A FEASIBILITY STUDY IN A PORCINE MODEL AND RECENT CLINICAL EXPERIENCE
|
Attawettayanon, Worapat
|
|
|
42 |
S |
p. S45
|
artikel
|
| 160 |
NON-MUSCLE INVASIVE RECURRENCE AND MANAGEMENT DURING SURVEILLANCE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WHO ACHIEVE CLINICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY
|
Joffe, Benjamin I.
|
|
|
42 |
S |
p. S33
|
artikel
|
| 161 |
NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES
|
Steinmetz, Alexis
|
|
|
42 |
S |
p. S47-S48
|
artikel
|
| 162 |
OBJECTIVE LONG-TERM BLADDER-RELATED QUALITY OF LIFE OUTCOMES FOLLOWING TRIMODALITY THERAPY
|
Egan, Jillian
|
|
|
42 |
S |
p. S23
|
artikel
|
| 163 |
OLIGOMETASTASIS THROUGH THE LENS OF PSMA-PET
|
Ghaffar, Umar
|
|
|
42 |
S |
p. S19-S20
|
artikel
|
| 164 |
ONCOLOGIC OUTCOMES OF BLADDER-SPARING MANAGEMENT FOR HIGH-GRADE NON-INVASIVE UROTHELIAL CARCINOMA OF THE PROSTATIC URETHRA
|
Martin, Alexander C.
|
|
|
42 |
S |
p. S45-S46
|
artikel
|
| 165 |
ONCOLOGIC OUTCOMES OF GEMCITABINE-DOCETAXEL COMBINATION INTRAVESICAL BLADDER SPARING THERAPY COMPARED TO UPFRONT RADICAL CYSTECTOMY IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
|
Annapureddy, Drupad
|
|
|
42 |
S |
p. S52-S53
|
artikel
|
| 166 |
ONCOLOGIC OUTCOMES OF INTRAVESICAL THERAPY IN THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY
|
Lone, Zaeem
|
|
|
42 |
S |
p. S71
|
artikel
|
| 167 |
ONCOLOGIC OUTCOMES OF SINGLE-PORT TRANSVESICAL AND MULTI-PORT TRANSPERITONEAL ROBOT-ASSISTED RADICAL PROSTATECTOMY
|
Soputro, Nicolas A
|
|
|
42 |
S |
p. S17
|
artikel
|
| 168 |
OUTCOMES AND PATIENT SATISFACTION FOLLOWING SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: A MODERN PERSPECTIVE
|
Lama, Daniel
|
|
|
42 |
S |
p. S75
|
artikel
|
| 169 |
OUTCOMES OF TRANSPERINEAL MRI-FUSION TARGETED PROSTATE BIOPSY UTILIZING PRECISIONPOINT VERSUS A GRID TEMPLATE
|
Buller, Dylan
|
|
|
42 |
S |
p. S87
|
artikel
|
| 170 |
OUTCOMES OF TRIMODAL THERAPY FOR CT2-3 UROTHELIAL CARCINOMA IN A MULTIETHNIC, DIVERSE POPULATION
|
Dave, Priya
|
|
|
42 |
S |
p. S30
|
artikel
|
| 171 |
OUTPATIENT EXERCISE, NUTRITION, PSYCHOLOGIC SUPPORT, AND PRE-/REHABILITATION FOR PROSTATE CANCER; A SCOPING REVIEW
|
Briggs, Logan
|
|
|
42 |
S |
p. S88-S89
|
artikel
|
| 172 |
PENILE SQUAMOUS CELL CARCINOMA SEER DATABASE ANALYSIS
|
Edwards, George
|
|
|
42 |
S |
p. S67
|
artikel
|
| 173 |
PHASE 1B/2 DOSE-EXPANSION, OPEN-LABEL STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER
|
Lyon, Timothy D.
|
|
|
42 |
S |
p. S64-S65
|
artikel
|
| 174 |
PIVOTAL STUDY OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: 5-YEAR FOLLOW UP
|
Eggener, Scott
|
|
|
42 |
S |
p. S83
|
artikel
|
| 175 |
POLYGENIC RISK SCORE IS ASSOCIATED WITH INCREASED RISK OF BLADDER CANCER AND EARLIER AGE AT DIAGNOSIS INDEPENDENT OF LIFESTYLE FACTORS
|
Nusbaum, David J.
|
|
|
42 |
S |
p. S33-S34
|
artikel
|
| 176 |
PORTAL HYPERTENSION IS NOT ASSOCIATED WITH ADVERSE SURGICAL OUTCOMES IN LEVEL IV TUMOR THROMBUS PATIENTS
|
Croll, Benjamin
|
|
|
42 |
S |
p. S71-S72
|
artikel
|
| 177 |
POSITIVE CTDNA STATUS BEFORE RADICAL CYSTECTOMY PREDICTS POOR OUTCOMES
|
Ben-David, Reuben
|
|
|
42 |
S |
p. S64
|
artikel
|
| 178 |
POTENTIAL FINANCIAL IMPACT OF THE INFLATION REDUCTION ACT FOR PATIENTS WITH PROSTATE CANCER
|
Pockros, Benjamin
|
|
|
42 |
S |
p. S9
|
artikel
|
| 179 |
PRE-CYSTECTOMY MAGNETIC RESONANCE IMAGING WITH SPECIFIC BLADDER PROTOCOL: DIAGNOSTIC UTILITY AND COMPARISON TO FINAL SURGICAL PATHOLOGY
|
Rodriguez-Mahon, Katherine
|
|
|
42 |
S |
p. S63
|
artikel
|
| 180 |
PRELIMINARY EFFECTIVENESS OF AMNIOTIC BLADDER THERAPY IN PATIENTS WITH CHRONIC RADIATION CYSTITIS
|
Jeberaeel, Julian
|
|
|
42 |
S |
p. S36
|
artikel
|
| 181 |
PREOPERATIVE FACTORS PREDICTIVE OF LOSS OF INDEPENDENCE FOLLOWING MAJOR UROLOGIC ONCOLOGY PROCEDURES
|
Boroda, Joseph
|
|
|
42 |
S |
p. S11-S12
|
artikel
|
| 182 |
PREOPERATIVE RADICAL CYSTECTOMY ERAS SCREENING AND EDUCATION – PATIENT REPORTED OUTCOMES
|
Miyagi, Hiroko
|
|
|
42 |
S |
p. S67-S68
|
artikel
|
| 183 |
PREVALENCE OF OCCULT UROLOGIC MALIGNANCIES IN PATIENTS UNDERGOING SCREENING FOR LUNG CANCER
|
Maldonado, Jonathan
|
|
|
42 |
S |
p. S35-S36
|
artikel
|
| 184 |
PRIMARY TUMOR RESPONSE TO PRE-OPERATIVE IMMUNE CHECKPOINT INHIBITION IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
|
Bhanvadia, Raj R
|
|
|
42 |
S |
p. S73
|
artikel
|
| 185 |
PROFILING THE TUMOR IMMUNE MICROENVIRONMENT OF PAPILLARY RENAL CELL CARCINOMA
|
Hayes, Mitch
|
|
|
42 |
S |
p. S6
|
artikel
|
| 186 |
PROPENSITY-MATCHED ANALYSIS OF OPEN VERSUS ROBOTIC PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR CS II TESTICULAR CANCER
|
Chavarriaga, Julian
|
|
|
42 |
S |
p. S104
|
artikel
|
| 187 |
PROSTATE MRI WITHOUT CONTRAST: OPPORTUNITY TO REDUCE FINANCIAL TOXICITY AND IMPROVE ACCESS FOR PATIENTS WITH PROSTATE CANCER
|
Pockros, Benjamin
|
|
|
42 |
S |
p. S96-S97
|
artikel
|
| 188 |
PROSTATE SPECIFIC ANTIGEN SCREENING AMONGST SMOKERS: A U.S. NATIONAL BEHAVIORAL ANALYSIS
|
Harmatz, I. Mitchell
|
|
|
42 |
S |
p. S76
|
artikel
|
| 189 |
PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET FOR INITIAL STAGING OF PROSTATE CANCER: AN ACADEMIC CENTER EXPERIENCE
|
Ghaffar, Umar
|
|
|
42 |
S |
p. S19
|
artikel
|
| 190 |
PSMA PET/CT-DETECTED MESORECTAL NODAL METASTASIS IN BIOCHEMICALLY RECURRENT PROSTATE CANCER PATIENTS
|
Sayyid, Rashid
|
|
|
42 |
S |
p. S17-S18
|
artikel
|
| 191 |
PSYCHOLOGICAL RESILIENCE AND DISTRESS AMONG RADICAL CYSTECTOMY PATIENTS: A SYMPTOM DISTRESS SCALE SURVEY ANALYSIS
|
Thomas, Kezia Reji
|
|
|
42 |
S |
p. S23-S24
|
artikel
|
| 192 |
“Published abstracts from the 24th Annual Meeting of the Society of Urologic Oncology”
|
Singer, Eric A.
|
|
|
42 |
S |
p. S1
|
artikel
|
| 193 |
QUANTIFICATION OF MICROPAPILLARY COMPONENT ON TRANSURETHRAL RESECTION OF BLADDER TUMOR: IMPACT ON LYMPH NODE METASTASIS AT RADICAL CYSTECTOMY
|
Wood, Andrew
|
|
|
42 |
S |
p. S46-S47
|
artikel
|
| 194 |
RACIAL EQUITY IN ACTIVE SURVEILLANCE UTILIZATION OF LOW- AND INTERMEDIATE-RISK MEN WITHIN THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC)
|
Mason, J. Bradley
|
|
|
42 |
S |
p. S98
|
artikel
|
| 195 |
RADIATION THERAPY AND IRREVERSIBLE ELECTROPORATION (RTIRE) FOR INTERMEDIATE RISK PROSTATE CANCER: A PHASE II ONGOING TRIAL
|
Calderon, Lina Posada
|
|
|
42 |
S |
p. S81
|
artikel
|
| 196 |
RATE AND OUTCOMES OF SNMMI “RARELY APPROPRIATE” PSMA PET/CT SCAN USE IN INITIAL STAGING AND BIOCHEMICALLY RECURRENT PROSTATE CANCER
|
Bennett IV, Richard
|
|
|
42 |
S |
p. S77-S78
|
artikel
|
| 197 |
RATES OF PROSTATE CANCER DIAGNOSIS IN MEN OF AFRICAN ANCESTRY USING MULTIPARAMETRIC MRI AND MRI/US FUSION-GUIDED BIOPSY
|
Gelikman, David G.
|
|
|
42 |
S |
p. S75-S76
|
artikel
|
| 198 |
REAL-WORLD ANALYSES OF MACE AND MORTALITY RISK IN PATIENTS WITH PROSTATE CANCER AFTER INITIATION OF LHRH AGONISTS VS. GNRH ANTAGONIST
|
Dorff, Tanya
|
|
|
42 |
S |
p. S18-S19
|
artikel
|
| 199 |
REAL-WORLD CLINICAL OUTCOMES OF MEDICARE PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION THERAPY OR RADICAL PROSTATECTOMY STRATIFIED BY RACE AND ETHNICITY
|
Karsh, Lawrence
|
|
|
42 |
S |
p. S16
|
artikel
|
| 200 |
REAL-WORLD EFFICACY OF ADJUVANT INTRAVESICAL GEMCITABINE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
|
Chakra, Mohamad Abou
|
|
|
42 |
S |
p. S54
|
artikel
|
| 201 |
REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
|
Morgans, Alicia K.
|
|
|
42 |
S |
p. S26-S27
|
artikel
|
| 202 |
RETHINKING THE DEFINITION OF STAGE IV DISEASE IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLININCAL LYMPH NODE POSITIVE DISEASE
|
Lichtbroun, Benjamin
|
|
|
42 |
S |
p. S102
|
artikel
|
| 203 |
RETROPERITONEAL NODAL DISTRIBUTION OF METASTATIC SEMINOMA: A CLINICAL MAPPING STUDY
|
Zeng, Jiping
|
|
|
42 |
S |
p. S8
|
artikel
|
| 204 |
RISK-BASED HEMATURIA REFERRAL PATTERNS AT A LARGE SINGLE INSTITUTION IN PATIENTS WITH NO PREVIOUS UROLOGIC EVALUATION
|
Bochner, Emily
|
|
|
42 |
S |
p. S66-S67
|
artikel
|
| 205 |
RISKS OF GRADE RECLASSIFICATION AMONG PATIENTS WITH GLEASON GRADE GROUP 1 PROSTATE CANCER AND PI-RADS 5 FINDINGS ON PROSTATE MRI
|
Sundaresan, Vinaik Mootha
|
|
|
42 |
S |
p. S79
|
artikel
|
| 206 |
RISK STRATIFYING PIRADS 4 LESIONS AND IDENTIFYING THOSE WITH VERY HIGH CANCER DETECTION RATES ON PROSTATE MRI
|
Canning, Caroline
|
|
|
42 |
S |
p. S75
|
artikel
|
| 207 |
ROLE OF RADICAL CYSTECTOMY IN MANAGEMENT OF BLADDER CANCER WITH CLINICAL EVIDENCE OF REGIONAL LYMPH NODE INVOLVEMENT AT US VETERANS HEALTH ADMINISTRATION FACILITIES
|
Meagher, Margaret F.
|
|
|
42 |
S |
p. S24
|
artikel
|
| 208 |
ROLE OF SELF-ASSESSED SOCIAL SUPPORT AND SOCIAL DEPRIVATION INDEX IN PREDICTING COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY
|
Dadabhoy, Anosh
|
|
|
42 |
S |
p. S59
|
artikel
|
| 209 |
ROLE OF T99MDP BONE SCAN AND AXIAL IMAGING IN THE PET PSMA ERA FOR INITIAL STAGING OF NEWLY DIAGNOSED PROSTATE CANCER
|
Bennett IV, Richard
|
|
|
42 |
S |
p. S78
|
artikel
|
| 210 |
ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY
|
Shinder, Brian
|
|
|
42 |
S |
p. S86-S87
|
artikel
|
| 211 |
SAFETY OF DRAINLESS MAJOR UROLOGIC SURGERIES: ANALYSIS OF THE 2019-2021 ACS NSQIP DATABASE
|
Pfail, John
|
|
|
42 |
S |
p. S94
|
artikel
|
| 212 |
SAFETY OF PARTIAL AND RADICAL NEPHRECTOMY FOR COMPLEX LOCALLY ADVANCED RENAL CELL CARCINOMA AFTER NEO-ADJUVANT IMMUNE CHECKPOINT INHIBITION (DURVALUMAB +/- TREMELIMUMAB)
|
Scovell, Jason M.
|
|
|
42 |
S |
p. S4
|
artikel
|
| 213 |
SALVAGE RADIOTHERAPY IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PSA PERSISTENCE OR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY DUE TO PROSTATE CANCER
|
Grabbert, Markus
|
|
|
42 |
S |
p. S17
|
artikel
|
| 214 |
SARCOPENIA IN MUSCLE-INVASIVE BLADDER CANCER (MIBC) PATIENTS WITH BORDERLINE PREOPERATIVE FENAL FUNCTION: A COHORT ANALYSIS
|
Haile, Eiftu
|
|
|
42 |
S |
p. S34
|
artikel
|
| 215 |
SCREENING WITH PSA AND MRI: YEARLY TRENDS BY PI-RADS AND RACE SHOWS STABLE DIAGNOSIS OF NCCN VERY LOW RISK DISEASE
|
Greenberg, Jacob W.
|
|
|
42 |
S |
p. S98
|
artikel
|
| 216 |
SELECTIVE USE OF NEOADJUVANT TKI ASSOCIATES WITH INCREASED ACHIEVEMENT OF PARTIAL NEPHRECTOMY FOR HIGH COMPLEXITY RENAL MASS IN A SOLITARY KIDNEY
|
Attawettayanon, Worapat
|
|
|
42 |
S |
p. S44-S45
|
artikel
|
| 217 |
SENTINEL-1: A FEASIBILITY STUDY OF FLUORESCENCE ENHANCED PELVIC LYMPH NODE DETECTION USING INTRAVESICAL HEXAMINOLEVULINATE HCL DYE FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
|
Huang, Emily
|
|
|
42 |
S |
p. S21-S22
|
artikel
|
| 218 |
SEQUENTIAL ENDOLUMINAL GEMCITABINE AND CABAZITAXEL WITH SYSTEMIC PEMBROLIZUMAB FOR RECURRENT NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS
|
McElree, Ian
|
|
|
42 |
S |
p. S61-S62
|
artikel
|
| 219 |
SHIFTING THE PARADIGM: THE INTRIGUING ROLE OF C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM -ANALYSIS OF THE INMARC REGISTRY
|
Saitta, Cesare
|
|
|
42 |
S |
p. S41
|
artikel
|
| 220 |
SINGLE-CELL RNA SEQUENCING ANALYSIS IDENTIFIES CHANGES IN TUMOR MICROENVIRONMENT INDUCED BY INTERFERON α GENE THERAPY IN A MURINE MODEL OF BLADDER CANCER
|
Mokkapati, Sharada
|
|
|
42 |
S |
p. S51
|
artikel
|
| 221 |
SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN ADMINISTRATION OF IMMUNOTHERAPY FOR ADVNACED UROTHELIAL CARCINOMA OF THE BLADDER
|
Holland, Levi
|
|
|
42 |
S |
p. S29-S30
|
artikel
|
| 222 |
SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN IMMUNOTHERAPY FOR ADVANCED CLEAR CELL RENAL CELL CARCINOMA
|
Holland, Levi
|
|
|
42 |
S |
p. S43
|
artikel
|
| 223 |
SQUAMOUS CELL CARCINOMA OF THE RENAL PELVIS: TREATMENT IMPACT AND SURVIVAL OUTCOMES IN THE NATIONAL CANCER DATABASE
|
Connors, Christopher
|
|
|
42 |
S |
p. S2-S3
|
artikel
|
| 224 |
SUBCUTANEOUS FAT AREA AS A RISK FACTOR FOR PARASTOMAL HERNIA FOLLOWING CYSTECTOMY AND ILEAL CONDUIT: DATA FROM THE PUBMIC TRIAL
|
Ghoreifi, Alireza
|
|
|
42 |
S |
p. S33
|
artikel
|
| 225 |
SUBOPTIMAL REPORTING OF ADVERSE EVENTS IN RCTs SUPPORTING BLADDER CANCER CLINICAL PRACTICE GUIDELINES
|
Anderson, Reece Michael
|
|
|
42 |
S |
p. S38
|
artikel
|
| 226 |
SWOG S1931 (PROBE): PHASE III RANDOMIZED TRIAL OF IMMUNE CHECKPOINT INHIBITOR (ICI) COMBINATION REGIMEN WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN) IN ADVANCED RENAL CANCER [NCT04510597]
|
Kim, Hyung
|
|
|
42 |
S |
p. S4
|
artikel
|
| 227 |
Table of Contents
|
|
|
|
42 |
S |
p. ii
|
artikel
|
| 228 |
TELEMEDICINE VISIT TYPE AND PATIENT SATISFACTION AND COSTS AMONG PATIENTS WITH UROLOGIC CANCER
|
Carson, Daniel
|
|
|
42 |
S |
p. S10
|
artikel
|
| 229 |
TESTOSTERONE RECOVERY AFTER ANDROGEN DEPRIVATION THERAPY
|
Ho, Austin Y.
|
|
|
42 |
S |
p. S74-S75
|
artikel
|
| 230 |
THE ADDED VALUE OF SYSTEMATIC SAMPLING IN IN-BORE MAGNETIC RESONANCY IMAGING GUIDED PROSTATE BIOPSY
|
Lazarovich, Alon
|
|
|
42 |
S |
p. S74
|
artikel
|
| 231 |
THE ASSOCIATION BETWEEN HEALTH LITERACY AND ALL-CAUSE MORTALITY IN UROLOGIC CANCER PATIENTS
|
Akinsola, Olutiwa
|
|
|
42 |
S |
p. S13
|
artikel
|
| 232 |
THE ASSOCIATION OF COUNTY-LEVEL PROSTATE-SPECIFIC ANTIGEN SCREENING WITH METASTATIC PROSTATE CANCER AND PROSTATE CANCER MORTALITY
|
Stone, Benjamin V.
|
|
|
42 |
S |
p. S79-S80
|
artikel
|
| 233 |
THE DISTRIBUTION OF MUTATIONS ACROSS TUMOR SIZE IN CCRCC AND THEIR PROGNOSTIC IMPORTANCE IN SMALL MASSES
|
Monda, Steven
|
|
|
42 |
S |
p. S7
|
artikel
|
| 234 |
THE EFFECT OF DUAL ELIGIBILITY ON THE QUALITY OF ACTIVE SURVEILLANCE IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER
|
Faraj, Kassem
|
|
|
42 |
S |
p. S99
|
artikel
|
| 235 |
THE EFFECT OF THE 340B DRUG PRICING PROGRAM ON ACCESS, OUT-OF-POCKET COSTS, AND ADHERENCE OF ORAL TARGETED AGENTS IN MEDICARE BENEFICIARIES WITH ADVANCED PROSTATE CANCER
|
Faraj, Kassem
|
|
|
42 |
S |
p. S10-S11
|
artikel
|
| 236 |
THE IMMEDIATE EFFECTS OF PRIVATE EQUITY ACQUISITION OF UROLOGY PRACTICES ON THE MANAGEMENT OF NEWLY DIAGNOSED PROSTATE CANCER
|
Faraj, Kassem S
|
|
|
42 |
S |
p. S11
|
artikel
|
| 237 |
THE IMPACT OF ABDOMINAL INSUFFLATION ON THE INTRAOCULAR PRESSURE DURING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY
|
Khan, Amir Farooq
|
|
|
42 |
S |
p. S86
|
artikel
|
| 238 |
THE PROGNOSTIC SIGNIFICANCE AND GENETIC PROFILE OF PROSTATE CANCER WITH EXPANSILE CRIBRIFORM GLEASON PATTERN 4
|
Pessoa, Rodrigo Rodrigues
|
|
|
42 |
S |
p. S100-S101
|
artikel
|
| 239 |
THE RELATIONSHIP BETWEEN SMOKING STATUS AND POOR MENTAL HEALTH IN BLADDER CANCER PATIENTS AND SURVIVORS
|
Alkatib, Khalid Y.
|
|
|
42 |
S |
p. S36-S37
|
artikel
|
| 240 |
THE ROLE OF OVARIAN PRESERVATION IN MAINTAINING SEXUAL FUNCTION AFTER RADICAL CYSTECTOMY
|
Chew, Lauren
|
|
|
42 |
S |
p. S37
|
artikel
|
| 241 |
TOLERABILITY OF LUTETIUM-177–PSMA-617 IN MEN WITH PROSTATE CANCER AND BASELINE CYTOPENIA
|
Ahmed, Mohamed E.
|
|
|
42 |
S |
p. S13
|
artikel
|
| 242 |
T3 PARTIAL NEPHRECTOMIES VERSUS RADICAL NEPHRECTOMIES: ONCOLOGICAL OUTCOMES
|
Boaretto, Daniel
|
|
|
42 |
S |
p. S72
|
artikel
|
| 243 |
TRANSPERINEAL PROSTATE BIOPSIES WITHOUT ROUTINE ADMINISTRATION OF PERIOPERATIVE ANTIBIOTICS – A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
|
Lichtbroun, Benjamin
|
|
|
42 |
S |
p. S96
|
artikel
|
| 244 |
TRANSPERINEAL VERSUS TRANSRECTAL MRI-US FUSION TARGETED PROSTATE BIOPSIES FOR APICAL LESIONS
|
Siva, Jayant
|
|
|
42 |
S |
p. S15-S16
|
artikel
|
| 245 |
TRANSVERSE VERSUS VERTICAL EXTRACTION SITE INCISION AFTER MINIMALLY INVASIVE RADICAL PROSTATECTOMY: A CLINICALLY INTEGRATED, CROSSOVER CLUSTER RANDOMIZED TRIAL
|
Gaffney, Christopher D
|
|
|
42 |
S |
p. S92
|
artikel
|
| 246 |
TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NONMUSCLE-INVASIVE BLADDER CANCER WITH UGN-102 ± TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) COMPARED TO TURBT MONOTHERAPY: THE PHASE 3 ATLAS TRIAL
|
Prasad, Sandip M.
|
|
|
42 |
S |
p. S57
|
artikel
|
| 247 |
ULTRASOUND ECHOGENICITY CAN RISK STRATIFY LESIONS ON MP-MRI FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
|
Wegner, Garret
|
|
|
42 |
S |
p. S76
|
artikel
|
| 248 |
UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSITICATION IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER
|
Singhal, Udit
|
|
|
42 |
S |
p. S84-S85
|
artikel
|
| 249 |
UNDERSTANDING THE RELATIONSHIP BETWEEN INSURANCE TYPE AND TESTICULAR GERM CELL TUMORS STAGE PRESENTATION USING THE NATIONAL CANCER DATABASE (NCDB)
|
Leff, Morgan A.
|
|
|
42 |
S |
p. S105-S106
|
artikel
|
| 250 |
UNDERUTILIZATION OF BEST SYSTEMIC THERAPY IN PATIENTS WITH METASTATIC PROSTATE CANCER: ASSESSMENT OF RACE AND SOCIOECONOMIC DISPARITIES
|
Roadman, Daniel
|
|
|
42 |
S |
p. S14
|
artikel
|
| 251 |
UNRAVELING THE WEB OF FRAILTY: A NOVEL APPROACH TO FRAILTY USING A COMPREHENSIVE GERIATRIC ASSESSMENT-DERIVED SPIDER PLOT
|
Cavanaugh, Dana
|
|
|
42 |
S |
p. S60
|
artikel
|
| 252 |
UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2
|
Catto, James WF
|
|
|
42 |
S |
p. S53
|
artikel
|
| 253 |
URINARY EXTRACELLULAR VESICLE PROTEINS AS SIGNATURES FOR CRIBRIFORM AND INTRADUCTAL PROSTATE CARCINOMA
|
Bernardino, Rui
|
|
|
42 |
S |
p. S101
|
artikel
|
| 254 |
UROLOGIC ONCOLOGY CASE VOLUME AMONG EARLY CAREER UROLOGISTS: AN ANALYSIS OF CERTIFICATION DATA FROM THE AMERICAN BOARD OF UROLOGY FROM 2014 TO 2019
|
Shukla, Devki
|
|
|
42 |
S |
p. S10
|
artikel
|
| 255 |
UROLOGIST PRACTICE DIVESTMENT FROM RADIATION VAULT OWNERSHIP AND TREATMENT PATTERNS FOR PROSTATE CANCER
|
Faraj, Kassem S
|
|
|
42 |
S |
p. S99
|
artikel
|
| 256 |
US CLINICAL PRACTICE PATTERNS OF INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER AMONG CARCINOMA IN SITU AND PAPILLARY-ONLY TUMORS
|
Chakra, Mohamad Abou
|
|
|
42 |
S |
p. S54-S55
|
artikel
|
| 257 |
UTILITY OF A URINE-BASED DNA METHYLATION TEST FOR SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER: A PILOT STUDY
|
Seyedian, Sanam Ladi
|
|
|
42 |
S |
p. S50-S51
|
artikel
|
| 258 |
UTILITY OF CIRCULATING TUMOR DNA STATUS IN PATIENTS WITH DIFFERENT STAGES OF TESTICULAR CANCER
|
Ben-David, Reuben
|
|
|
42 |
S |
p. S106
|
artikel
|
| 259 |
UTILITY OF MRI FOR TRANSRECTACL VS. TRANSPERINEAL BIOPSIES: ARE WE HEADED IN THE RIGHT DIRECTION?
|
O'Connor, Luke P.
|
|
|
42 |
S |
p. S81
|
artikel
|
| 260 |
UTILIZING LOW-PASS WHOLE GENOME SEQUENCING OF URINARY-TUMOR DNA TO IDENTIFY MINIMAL RESIDUAL DISEASE PRIOR TO REPEAT TRANSURETHRAL RESECTION OF BLADDER TUMOR
|
Murthy, Prithvi
|
|
|
42 |
S |
p. S50
|
artikel
|
| 261 |
VALIDATION OF A BLOOD-BASED SPHINGOLIPID PANEL FOR MEN WITH LOCALIZED PROSTATE CANCER ON ACTIVE SURVEILLANCE
|
Gregg, Justin R.
|
|
|
42 |
S |
p. S80-S81
|
artikel
|
| 262 |
VALUE OF B7-H3 EXPRESSION AS A PREDICTOR OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN UROTHELIAL CELL CARCINOMA OF BLADDER
|
Nabavizadeh, Reza
|
|
|
42 |
S |
p. S30-S31
|
artikel
|
| 263 |
VIRTUAL CARE AS A TOOL TO IMPROVE HEALTH EQUITY? A NATIONAL RACIAL AND ETHNIC ANALYSIS OF TELEMEDICINE UTILIZATION AMONG CANCER PATIENTS AND SURVIVORS DURING COVID-19
|
Cortese, Brian D.
|
|
|
42 |
S |
p. S9-S10
|
artikel
|
Tijdschrift beschrijving